baber/WOPTO huggingface dataset:
Patent NZ-578073-A (NZ)
Title: A debris screen and a device including a debris screen for removing solid debris from water stream
Inventor: EYLEY BRIAN
IPC: E04D13/04
Filed: 2009-06-30
Abstract: A device 1 for screening solid matter from water that is directed into a water collector, comprises a housing 3 enclosing a chamber, the housing 3 comprising a bottom wall 5 and a side wall 7 extending up from the bottom wall 5 to an upper edge, the side wall including a rear wall portion for mounting the housing to a support, and an opposed front wall portion 14, the upper edge of the side wall defines an upwardly facing water inlet through which water enters the chamber, and the housing defines a water outlet spaced beneath the inlet through which water is discharged from the chamber, and a debris screen 41 mounted on the housing for screening debris out of water passing through the water inlet. The debris screen has substantially coextensive upper and lower screen faces that are connected around their peripheral edges by a rear edge and a front edge that correspond to the rear and front portions of the housing, and two opposed side edges 47, 49 extending between the rear and front edges. The screen face curves downwardly from the rear edge to the front edge of the screen. The screen is mounted on the housing 7 in such a way that it can be moved out of its operative position.
Patent NZ-586868-A (NZ)
Title: Process for preparing orally administered dabigatran formulations
Inventor: LANDERER SABINE
IPC: A61K31/4439
Filed: 2009-03-24
Abstract: Disclosed is a process for preparing a suspension of the polymorph form I of the methanesulphonic acid salt of dabigatran etexilate, represented by general formula (I), comprising: Suspending polymorph form I of dabigatran etexilate methanesulphonate and talc together in a solution of hydroxypropylcellulose in isopropanol, wherein the preparation of the suspension is carried out at a temperature 30 degrees Celsius or below.
Patent NZ-590443-A (NZ)
Title: Film cutting and transfer device where the film is held by suction on the blade roll
Inventor: YAMAMOTO HIROKI
IPC: A61F13/49
Filed: 2009-06-30
Abstract: An intermittent cutting transferring device configured to cut a first web 10A into individual sheets 10 and to intermittently transfer the individual sheets 10 onto a continuously fed second web 20, comprises an upper blade roll 30 which has a blade 32 on an outer peripheral surface, and a lower blade roll 40 with an anvil on an outer peripheral surface and a plurality of suction holes 43. The upper blade roll 30 and the lower blade roll 40 are rotatable in opposite roll rotating directions at approximately the same peripheral velocity which is higher than a velocity in which the first web 10A is fed to the lower blade roll, and equal to or lower than a feeding velocity of the second web 20. The blade and the anvil are configured to guide the first web 10A there between while the first web 10A is being sucked onto the outer peripheral surface of the lower blade roll 40 by suction through the plurality of suction holes formed in a first region of the outer peripheral surface of the lower blade roll. The blade and the anvil are adapted to be brought into contact with each other to intermittently cut the first web 10A into the individual sheets 10. Each of the individual sheets cut from the first web 10A is arranged to be guided and transferred onto the second web 20 while the sheet is being sucked onto the outer peripheral surface of the lower blade roll 40 by suction through the suction holes 43 formed in a second region on the outer peripheral surface of the lower blade roll 40. The first region includes a suction region in which the plurality of the suction holes are formed and a non-suction region free of the suction holes. The suction region and the non-suction region are provided alternately in the roll rotating direction of the lower blade roll 40. The closest distance between adjacent suction holes in the roll rotating direction of the lower blade roll and the closest distance between adjacent suction holes in a roll width direction substantially perpendicular to the roll rotating direction are smaller than a diameter of each the suction hole. The suction region includes first and second inclined regions in which the suction holes are arranged in rows inclined to the roll width direction. The first inclined region is provided on one side of a centre line passing through the centre of the lower blade roll in the roll width direction and the second inclined region is provided on the other side of the centre line, and the rows of suction holes in the first and the second inclined regions both converge toward the centre line in the roll rotating direction of the lower blade roll 40.
Patent NZ-590753-A (NZ)
Title: Processes for the preparation of 4-oxo-octahydro-indole-1-carbocylic acid methyl ester and derivatives thereof
Inventor: KUESTERS ERNST
IPC: C07C271/24
Filed: 2009-08-10
Abstract: A process for the production of (3aR, 4S, 7aR)-4-hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester of the formula (I), which comprises reacting 3-ethynyltoluene with of carbamic acid (2-chloroethyl)(3-oxocyclohexyl)-alkyl ester of formula (III) represented herein, to form the compound of formula (I) and optionally converting the compound of formula (I) to a pharmaceutically acceptable salt, wherein the compound of formula (III) is obtained by cyclisation of 1-carbalkoxy-4-ketoperhydroindole of the formula (II) as shown herein.
Patent NZ-594950-A (NZ)
Title: Treatment of leukemias and chronic myeloproliferative diseases with antibodies to epha3
Inventor: BEBBINGTON CHRISTOPHER R
IPC: A61K39/00
Filed: 2010-03-05
Abstract: Patent No. 594950 Disclosed is the use of an anti-EphA3 antibody in the manufacture of a medicament for treating a myeloproliferative disorder in a patient, wherein the patient has myeloproliferative disorder cells that express EphA3 on the cell surface and wherein the anti-EphA3 antibody (i) activates EphA3 and (ii) induces ADCC. Also disclosed is a method of monitoring the efficacy of treatment of a patient having a myeloproliferative disorder with EphA3+ myeloproliferative cells, wherein the myeloproliferative disorder is AML or MDS, the method comprising: providing a sample previously obtained from the patient comprising myeloproliferative disorder stem cells and/or blast cells from the patient following a therapeutic treatment for the myeloproliferative disorder; and detecting expression of EphA3 on the myeloproliferative disorder stem cells and/or blast cells.
Patent NZ-595433-A (NZ)
Title: 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
Inventor: HUFNAGEL HEATHER RAE
IPC: A61K31/397
Filed: 2010-04-15
Abstract: 595433 The disclosure is directed to substituted dipiperidine compounds of Formula (I), wherein X, R1, R2, R3, and R4 are defined in the specification and R1 is bound to the main skeleton of the Formula (I) by a heteroatom. Compounds of Formula (I) are antagonists to the chemoattractant cytokine receptor 2 (CCR2). More particularly, the CCR2 antagonists are substituted piperidyl acrylamide compounds useful for preventing, treating or ameliorating a CCR2 mediated syndrome, disorder or disease. The disclosure also relates to pharmaceutical compositions and medicaments of these compounds for use in preventing, treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease includes type II diabetes, obesity and asthma. Examples of compounds of Formula (I) include: N-({ 1-[4-(Pyrimidin-4-yloxy)-cyclohexyl]-azetidin-3-ylcarbamoyl} -methyl)-3-trifluoromethyl-benzamide N-({ 1-[4-(5-Methyl-pyridin-2-yloxy)-cyclohexyl]-azetidin-3-ylcarbamoyl} -methyl)-3-trifluoromethyl-benzamide N-({ 1-[4-(4-Methyl-pyridin-2-yloxy)-cyclohexyl]-azetidin-3-ylcarbamoyl} -methyl)-3-trifluoromethyl-benzamide N-({ 1-[4-(4-Iodo-pyrazol-1-yl)-cyclohexyl]-azetidin-3-ylcarbamoyl} -methyl)-3-trifluoromethyl-benzamide N-({ 1-[4-(3-Benzo[1,3]dioxol-5-yl-ureido)-cyclohexyl]-azetidin-3-ylcarbamoyl} -methyl)-3-trifluoromethyl-benzamide N-({ 1-[4-(2,5-Dimethyl-pyrrol-1-yl)-cyclohexyl]-azetidin-3-ylcarbamoyl} -methyl)-3-trifluoromethyl-benzamide
Patent NZ-597580-A (NZ)
Title: Polypeptides selective for alpha.v.beta.3 integrin conjugated with a variant of human serum albumin (hsa) and pharmaceutical uses thereof
Inventor: FU WEN-MEI
IPC: A61K38/00
Filed: 2010-07-19
Abstract: 597580 Discloses is a polypeptide comprising a variant of human serum albumin (HSA) with a C34S or C34A mutation which is bound to SEQ ID NO: 1 as defined herein. SEQ ID NO: 1GKECDCSSPENPCCDAATCKLRPGAQCGEGLCCEQCKFSRAGKICRIARLDDLDDRCTGQSADCPRYH
Patent NZ-598261-A (NZ)
Title: Post-harvest treatment
Inventor: HAUSER-HAHN ISOLDE
IPC: A01N3/02
Filed: 2008-09-02
Abstract: Disclsoed herein is the use of trifloxystrobin and salts thereof to protect harvested fruit or vegetables against phytopathogenic fungi, characterized in that diseases are caused by the fungi selected from Fusarium spp., Verticillium spp., Nigrospora spp.; Phytophthora spp., Septoria spp., Mucor spp., Monilinia spp., Venturia spp., Glomerella spp., Sclerotinia spp., Ceratocystis spp., Gloeosporium spp., Phlyctaena spp., Cylindrocarpon spp., Stemphyllium spp., Phacydiopycnis spp., Thielaviopsis spp., Aspergillus spp., Nectria spp., Pezicula spp.
Patent NZ-601660-A (NZ)
Title: Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
Inventor: DEAN NICHOLAS M
IPC: C12N15/113
Filed: 2009-08-25
Abstract: 601660 Disclosed is a compound which comprises a modified oligonucleotide consisting of 12 -30 linked nucleosides, at least a 12 nucleobase sequence portion of which is complementary to nucleotides within the region selected from nucleotides 718-751, 1388-1423, 2728-2797, 1394-1423, 1659-1689, 2100-2129 and 1399-1423 of SEQ ID NO: 9, wherein the modified oligonucleotide comprises (a) a gap segment consisting of linked deoxynucleosides; (b) a 5’ wing segment consisting of linked modified nucleosides; and (c) a 3’ wing segment consisting of linked modified nucleosides; wherein the gap segment is positioned between the 5’ wing segment and the 3’ wing segment and wherein each modified nucleoside within each wing segment comprises a modified sugar. Further disclosed is a compound which comprises a modified oligonucleotide consisting of 12 - 30 linked nucleosides, at least a 12 nucleobase sequence portion of which is complementary to nucleotides within the region selected from nucleotides 1457-1689, 2120-2147,2267-2301,553-611,1469-1508 and 1559-1605 of SEQ ID NO: 9, wherein the modified oligonucleotide comprises (a) a gap segment consisting of linked deoxynucleosides; (b) a 5’ wing segment consisting of linked modified nucleosides; and (c) a 3’ wing segment consisting of linked modified nucleosides; wherein the gap segment is positioned between the 5’ wing segment and the 3’ wing segment and wherein each modified nucleoside within each wing segment comprises a modified sugar; and wherein the compound demonstrates at least 60% inhibition in a human connective tissue growth factor expression assay.
Patent NZ-602454-A (NZ)
Title: An anchor
Inventor: SMITH PETER KEVIN
IPC: B63B21/24
Filed: 2012-09-17
Abstract: An anchor 1 including a shank 2 which in transverse cross section A-A along at least part of the length of the shank 2 has a forward facing edge 15, a rearward facing edge 16 and a pair of side faces 17, 18 between the forward facing edge 15 and the rearward facing edge 16. The parts 19 of the shank 2 adjacent to the forward facing edge are substantially “v” shaped in cross section. At least part of the side faces 17, 18 between the substantially “v” shaped part and the rearward facing edges has a concave face along the length of each side face. Each concave face has no substantial change of curvature along the length of the side face. The shape enables the anchor to dig itself easier into the sea bed.
Patent NZ-610826-A (NZ)
Title: Compositons and methods for targeting type 1 interferon producing cells
Inventor: PANOUSIS CON
IPC: A61K39/395
Filed: 2011-02-17
Abstract: Disclosed is the use of an immunoglobulin which binds an interleukin 3 receptor α (IL-3Rα) chain and which depletes or at least partly eliminates plasmacytoid dendritic cells (pDCs) and basophils to which it binds in the manufacture of a medicament for treating lupus in a mammal, wherein the immunoglobulin is not conjugated to a toxic compound that kills a cell to which the immunoglobulin binds, and wherein the immunoglobulin is capable of inducing an enhanced level of effector function.
Patent NZ-616408-A (NZ)
Title: A system for alerting a person or persons of a public transport hazard
Inventor: MARTIN PATRICK JOHN
IPC: G08B5/36
Filed: 2013-10-08
Abstract: Disclosed is a system for alerting a person or persons of a public transport vehicle hazard. The system is comprised of a location at which point the vehicle stops (‘boarding zone’); a location adjacent the boarding zone (‘hazard zone’) where the person or persons board the vehicle; a public transport vehicle; and at least one light mounted onto a surface proximate to or within the hazard zone. The light or lights are operatively connected to a sensor or sensors that detect the presence of the vehicle approaching the hazard zone. The sensor activates the lights when the vehicle approaches and/or enters the hazard zone thereby providing the person or persons with a visual warning of the approach of the vehicle. The light or lights may be activated when the vehicle is within between 0.5 and 100 metres of the hazard zone.
Patent NZ-624262-A (NZ)
Title: Support metal structure for a false ceiling
Inventor: CIPRIANI GIUSEPPE
IPC: E04B9/12
Filed: 2012-11-07
Abstract: A steel support (2) for false ceilings or for supporting false ceilings and process for making. The support being made of a steel strip of 0.25mm or less. The support has the following combination of features: maximum tensile strength (Rm) greater than 500 N/mm and elongation of from 0% to 15%.
Patent NZ-703607-A (NZ)
Title: Heteroaromatic compounds as bruton’s tyrosine kinase (btk) inhibitors
Inventor: BENTZIEN JOERG MARTIN
IPC: C07D417/06
Filed: 2013-08-08
Abstract: The present invention encompasses compounds of the formula (I) wherein the groups A, Cy, XI and Y are defined herein, which are suitable for the treatment of a disease chosen from rheumatoid arthritis, systemic lupus erythromatosis, scleroderma, asthma, allergic rhinitis, allergic eczema, B cell lymphoma, multiple sclerosis, juvenile rheumatoid arthritis, juvenile idiopathic arthritis, inflammatory bowel disease, graft versus host disease, psoriatic arthritis, ankylosing spondylitis and uveitis.
Patent NZ-703825-A (NZ)
Title: An apparatus and process for printing different images onto a substrate such as a preformed can or bottle
Inventor: TRELOAR STEPHEN
IPC: B41F7/16
Filed: 2013-07-10
Abstract: The present invention relates to an apparatus, process and set of plates for printing. For example, the present invention can relate to a single printing station in which a first cylinder having a printing plate with an inked region operates with the second cylinder having at least one transfer plate, and suitably multiple transfer plates such as rubber blankets, wherein the transfer plates are adapted so as to have an inked region and a non- inked region. The inked region and the non-inked region of the transfer plate registering with the inked region of the printing plate so as to determine the content of the image printed.
Patent NZ-704045-A (NZ)
Title: Apparatus, method and system for securing items to a post
Inventor: WHITE MARK
IPC: F16B2/20
Filed: 2013-08-28
Abstract: Existing systems for attaching wire to a fence post can require a high degree of manual labour, and some of the ties employed also require special tools and the services of a skilled fencer. For posts provided with spaced passages, usually an additional, complex and costly retention system is factory-fitted to the post in a separate process. The present invention provides an apparatus, method and system for securing at least one item to a post. The apparatus comprises an elongate element having a retaining portion, and two projecting portions. The projecting portions are of different lengths, such that the position of the retaining portion is variable with respect to a given pair of apertures. The apparatus, method and system find particular application in fencing to secure wire strands to a fence post, though they can be employed in applications such as demarcation, signage, retention, barricades etc.
Patent NZ-709552-A (NZ)
Title: Counter
Inventor: DUIGNAN CATHAL
IPC: G06M1/26
Filed: 2013-12-18
Abstract: This invention generally relates to counters and in particular to counters for use with dispensers and to dispensers comprising said counters. More particularly the present invention relates to counters for use with metered-dose dispensers, such as metered-dose inhalers (MDIs). In particular, the present invention provides a counter comprising: a first ring member having a first indicia and being rotatable in increments about an axis, the first indicia indicating a count; and a limiting member comprising a limiting mechanism, wherein the limiting mechanism comprises an engaging portion arranged to act radially with respect to the first ring member to contact the first ring member to limit free rotation of the first ring member relative to the limiting member about the axis; and a guide, the guide comprising an arm spaced apart from the limiting member engaging portion in a fixed relation, the guide being configured to contact the first ring member such that the limiting member engaging portion maintains contact with the first ring member. By providing a limiting mechanism that acts radially on the first ring member, this alleviates the problems associated with manufacturing tolerances in the vertical direction, which is perpendicular to the radial direction acting on the first ring member. As a result, more reliable operation of the limiting mechanism is enabled.
Patent NZ-711026-A (NZ)
Title: Processes and intermediates for preparing a medicament
Inventor: HOUPIS IOANNIS NICOLAOS
IPC: A61P29/00
Filed: 2014-03-11
Abstract: Disclosed is a process for the preparation of the following compounds: (I), (II) where R1, R1a and R2a have the definitions in the description, as well as a process to prepare other intermediates that may be useful to synthesise downstream products, especially compounds that are useful as medicaments, for instance Bruton’s tyrosine kinase (Btk) inhibitors such as ibrutinib. Also disclosed are other processes, other intermediates and compounds per se.
Patent NZ-717749-A (NZ)
Title: Heterocycle-substituted bicyclic azole pesticides
Inventor: CLARK DAVID
IPC: C07D513/04
Filed: 2014-09-09
Abstract: Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, and A, R1, m, X1, X2, X3, X4, Y1, Y2 and Y3 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound or a composition of the invention.
Patent NZ-717781-A (NZ)
Title: System and method for modular data center
Inventor: WILCOX ERIC
IPC: H05K7/20
Filed: 2014-10-02
Abstract: A modular data center (10) is disclosed. The modular data center may have a plurality of unit structures arranged generally parallel to one another. A plurality of supports (16) may be used for supporting the unit structures elevationally above a floor, and wherein adjacent ones of the unit structures form hot aisles (17) therebetween through which hot air generated from equipment racks (14) may be channeled. Each unit structure may form an elongated structure having a frame structure (28), a roof panel (42) supported by the frame structure, and a ceiling panel (26). The unit structures may be used to channel cold air to the equipment racks (14) and hot air from the hot aisles out from the unit structures. The invention aims to provide a data center construction structure that is cost-effective and efficient.
Patent NZ-720608-A (NZ)
Title: Β-glucan assay methods
Inventor: BOSE NANDITA
IPC: G01N33/53
Filed: 2014-12-01
Abstract: This disclosure provides, in one aspect, a method for analyzing a sample from a subject for a biomarker that is indicative of the subject’s immune response to β-glucan. Generally, the method includes obtaining a biological sample from a subject, analyzing the sample for a biomarker anti-β-glucan antibody compared to a reference standard, computing a Relative Antibody Unit (RAU) value for anti-β-glucan antibody in the sample, and identifying the subject as biomarker positive if the RAU value is greater than a predetermined RAU value for the biomarker anti-β-glucan antibody.
Patent NZ-727157-A (NZ)
Title: Non-human animals having a humanized programmed cell death 1 gene
Inventor: LAI KA-MAN VENUS
IPC: C07K16/28
Filed: 2015-06-19
Abstract: Non-human animals, and methods and compositions for making and using the same, are provided, wherein said non-human animals comprise a humanization of a Programmed cell death 1 (Pdcd1) gene. Said non-human animals may be described, in some embodiments, as having a genetic modification to an endogenous Pdcd1 gene so that said non-human animals express a PD-1 polypeptide that includes a human portion and an endogenous portion (e.g., a non-human portion).
Patent NZ-730623-A (NZ)
Title: Beverage container with improved piercing possibility
Inventor: SCHWARTZ ERHARD
IPC: B65D75/58
Filed: 2013-07-29
Abstract: Beverage container (1), in particular beverage pouch, which is provided with a piercing opening (2) for piercing with a drinking straw (5), in which beverage container (1) the piercing opening (2) is stamped and, on the inside, an outwardly exposed closure foil is fastened to the inner side around the piercing opening (2) by means of a welded joint (7), with the result that a sealed closure is produced, characterized in that a pocket (6) is formed between the inner welded edge (3) of the welded joint (7) and the lower edge (2b) of the piercing opening (2), in which pocket (6) the material of the beverage container (1) and the closure foil are not connected to one another.
Patent NZ-730809-A (NZ)
Title: Methods for treating filoviridae virus infections
Inventor: SIEGEL DUSTIN
IPC: A61P31/14
Filed: 2015-10-29
Abstract: Provided are a compound, methods, and pharmaceutical compositions for treating Filoviridae virus infections by administering the provided compound: The compound, compositions, and methods provided are particularly useful for the treatment of Marburg virus, Ebola virus and Cueva virus infections.